We are live on ! Find out more
RGN

REGENERX BIOPHARMACEUTICALS
RGN

Delisted

RGN was delisted on the 22nd of December, 2010.

Back to rankings

2 hedge funds and large institutions have $70K invested in REGENERX BIOPHARMACEUTICALS in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more capital invested

Capital invested by funds: $45K → $70K (+$25K)

33% less funds holding

Funds holding: 3 → 2 (-1)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
2
Holders Change
-1
Holders Change %
-33.33%
% of All Funds
0.04%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
CG
Colony Group
Massachusetts
-$3K

RGN Hedge Fund Activity: Q2 2020 in Review

2 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in REGENERX BIOPHARMACEUTICALS (RGN) for Q2 2020, worth a combined $70K — up 56% from $45K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of RGN and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was Colony Group, exiting entirely with an estimated $3K sold.

  • 2 institutional investors held REGENERX BIOPHARMACEUTICALS (RGN) as of Q2 2020, down from 3 in Q1 2020.
  • Funds reported $70K of REGENERX BIOPHARMACEUTICALS stock for Q2 2020, up 56% quarter-over-quarter.
  • 0 funds opened new REGENERX BIOPHARMACEUTICALS positions in Q2 2020 and 1 closed out, a net change of -1 holder.
  • The largest REGENERX BIOPHARMACEUTICALS seller in Q2 2020 was Colony Group, an estimated $3K sold.

Based on aggregated 13F filings for Q2 2020.